EM2112F "Treatment and Prevention of Hepatocellular Carcinoma" (IM GR-121021)
Purpose & Overview: To overview current epidemiology and emerging treatment and preventive interventions in hepatocellular carcinoma (HCC)
Target Audience
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
Learning Objectives
At the conclusion of this activity, the participant should be able to:
- Describe evolving HCC epidemiology in the U.S.
- Explain new medical therapies for advanced-stage HCC
- Explain new biomarkers to improve early HCC detection
- Review challenges and strategy for developing HCC chemoprevention
Yujin Hoshida, M.D., Ph.D.
Associate Professor of Internal Medicine
Division of Digestive and Liver Diseases
Available Credit
- 1.00 AMA
Price
Cost:
$0.00
Please login or create an account to take this course.
Required Hardware/software
Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox and Google Chrome